New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (12) , 3623-3627
Abstract
No abstract availableKeywords
Funding Information
- Portuguese Fundação para a Ciência e Tecnologia (SFRH/BPD/29874/2006)
- NIH (P41 RR-01081)
This publication has 22 references indexed in Scilit:
- Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: Developing a structure–activity relationshipBioorganic & Medicinal Chemistry Letters, 2009
- Dual Inhibitors of Matrix Metalloproteinases and Carbonic Anhydrases: Iminodiacetyl-Based Hydroxamate−Benzenesulfonamide ConjugatesJournal of Medicinal Chemistry, 2008
- Carbonic Anhydrases An OverviewCurrent Pharmaceutical Design, 2008
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activatorsNature Reviews Drug Discovery, 2008
- Carbonic Anhydrase Inhibitors: Inhibition of Isozymes I, II, and IX with Triazole-Linked O-Glycosides of Benzene SulfonamidesJournal of Medicinal Chemistry, 2007
- 2-Substituted Estradiol Bis-sulfamates, Multitargeted Antitumor Agents: Synthesis, In Vitro SAR, Protein Crystallography, and In Vivo ActivityJournal of Medicinal Chemistry, 2006
- Potent, Selective Pyrone-Based Inhibitors of Stromelysin-1Journal of the American Chemical Society, 2005
- Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14Bioorganic & Medicinal Chemistry Letters, 2005
- New Beginnings for Matrix Metalloproteinase Inhibitors: Identification of High-Affinity Zinc-Binding GroupsJournal of the American Chemical Society, 2004
- Carbonic anhydrase inhibitorsMedicinal Research Reviews, 2002